To exclude the causality between methylation of the given CpG sites and the expression of CLK4, we treated ESCC cells with 5‐aza‐2′‐deoxycytidine (5′‐Aza), a DNA methyltransferase (DNMT) inhibitor. Here, CLK4 is linked to esophageal squamous cell carcinoma.